Yu Q et al.A New Adjuvant MTOM Mediates Mycobacterium tuberculosis Subunit Vaccine to Enhance Th1-Type T Cell Immune Responses and IL-2(+) T Cells.Front Immunol 8:585 (2017).
Ng HI et al.Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.Sci Rep 6:29368 (2016).
Teng X et al.Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.Hum Vaccin Immunother 11:1456-64 (2015).
Wang X et al.Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-?+ IL-2+ CD4+ and IFN-?+ CD8+ T cells.PLoS One 10:e0122560 (2015).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"